About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Migrated Intrauterine Contraceptive Device: Incidental Finding in the Descending Sigmoid Colon
Cipta Pramana1, Gede Raditya Yoga2, Hosein Ivan Setiabudi2
1Department of Obstetrics and Gynecology, K.R.M.T. Wongsonegoro General Hospital Semarang, Indonesia/ Medicine Faculty of Tarumanagara University Jakarta, Indonesia; 2Medicine Faculty of Tarumanagara University Jakarta, Indonesia. 
Corresponding Author:
Dr. Cipta Pramana
Email: pramanacipta@yahoo.com
Received: 17-MAR-2020 Accepted: 03-JUL-2020 Published Online: 25-JUL-2020
DOI: http://dx.doi.org/10.17659/01.2020.0040
Abstract
Background: The migration of the intra-uterine device (IUD) to the colon is a rare but can cause serious complications. Removal of migrated IUD is highly recommended considering that it can lead to risks of complications, such as fistula formation and colonic perforation. Case Report: We hereby report 45-year-old woman with IUD implanted in the sigmoid intestine, which was removed by laparotomy and laparoscopy. Conclusion: The migration of IUD must be treated even in asymptomatic patients due to the risk of severe complications.
Keywords : Colonic Diseases, Fistula, Laparoscopy, Laparotomy, Sigmoid Colon.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jun 15, 2025